Back to results
US 2022/0177880 A1Published application
Double-stranded nucleic acid inhibitor molecules with shortened sense strands
AssigneeDicerna Pharmaceuticals, Inc.
InventorsBob Dale BROWN, Weimin WANG, Naim NAZEF
Life of this patent
Estimating the term…
Abstract
Provided herein are double-stranded nucleic acid inhibitor molecules having a shortened sense strand with a stem loop structure and an antisense strand. Also provided are methods and compositions for reducing target gene expression and methods and compositions for treating a disease of interest.
Claims43
A double-stranded nucleic acid inhibitor molecule, comprising:
- a sense strand comprising 15-43 nucleotides and having a first region (R1) and a second region (R2);
- an antisense strand comprising 18-35 nucleotides and a 5′- and 3′-end, wherein the antisense strand has a single stranded overhang of 6-10 nucleotides at the 3′-end and wherein the sense strand and antisense strand are separate strands;
- a first duplex (D1) formed by the first region of the sense strand and the antisense strand, wherein the first duplex has a length of 8-29 base pairs;
- wherein the second region of the sense strand comprises a first subregion (S1), a second subregion (S2) and a single stranded loop that joins the first and second subregions, wherein the first and second subregions form a second duplex (D2);
- and
- wherein the second duplex has a length of 6 base pairs and does not contain a Tm-increasing nucleotide or has a length of 1-5 base pairs and comprises at least one Tm-increasing nucleotide.
3 more elements
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.